Newly released article on another company in the immunotherapy field.
http://seekingalpha.com/article/309610-immunocellular-the-potential-for-a-cancer-vaccine
Although the momentum has been lost for PRR recently due to market sentiment the feeling I get from all the articles and news about the field of immunotherapy is the sentiment is strongly favourable for the sector for those with a long term perspective.
For example the phase I trial results for ICT107 being described as "we think it’s a real phenomenon," "So I think what we’re seeing is really some pretty amazing outcomes,"
The risk reward ratio in the cancer immunotherapy sector is gradually swinging toward the reward IMHO.
Holding grimly.
immunocellular therapies- good read
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
0.040(11.0%) |
Mkt cap ! $588.3M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 40.5¢ | 36.8¢ | $1.822M | 4.681M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19739 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 45420 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |